Literature DB >> 24603349

Sight-threatening ocular manifestations of acute febrile neutrophilic dermatosis (Sweet's syndrome).

Brandon Baartman1, Payman Kosari, Clinton C Warren, Saba Ali, Joseph L Jorizzo, Masaki Sato, Shree K Kurup.   

Abstract

Sweet's syndrome is a primarily dermatologic disorder with many features of systemic inflammation. It is generally characterized by a neutrophilic dermatosis in the setting of fever and an elevated white blood cell count. Inflammation has been described to occur in many organ systems including the lung, bone, liver, spleen, brain and eye. Ocular inflammation is a well-known comorbidity that may occur in the setting of Sweet's syndrome, including conjunctivitis, episcleritis, scleritis, iritis and choroiditis, among other forms. In the current article, we have compiled a series of cases that describe three separate patients who demonstrated a rare form of ocular involvement in Sweet's syndrome, retinal vasculitis. The evidence from these three cases and other reports in recent ophthalmologic literature suggest overlapping of ocular manifestations of Sweet's syndrome and the closely related Behçet's disease. It is important to be aware of the sometimes challenging differential between these two disorders and their sight-threatening complications.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24603349     DOI: 10.1159/000357729

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  3 in total

1.  Panuveitis in Sweet syndrome.

Authors:  Kelvin Ngan; James C Y Leong; Helen Long
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

2.  A Rare Case of Midostaurin-Associated Sweet's Syndrome.

Authors:  Hesham Yasin; Tessa Laytem; Grerk Sutamtewagul; Sabarish Ayyappan
Journal:  Case Rep Hematol       Date:  2022-04-22

3.  Oral tacrolimus for ocular involvement in pediatric neutrophilic dermatoses.

Authors:  Caitlan Swaffar; Diana McShane; Paul Googe; Leonard Kovalick; Dean S Morrell; Eveline Y Wu
Journal:  JAAD Case Rep       Date:  2022-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.